Liraglutide, a GLP-1 Receptor Agonist, Mitigates LPS-Induced Osteoclastogenesis and Bone Loss by Downregulating Macrophage TNF-α Expression.

Saved in:
Bibliographic Details
Title: Liraglutide, a GLP-1 Receptor Agonist, Mitigates LPS-Induced Osteoclastogenesis and Bone Loss by Downregulating Macrophage TNF-α Expression.
Authors: Murakami, Kou1 (AUTHOR), Kitaura, Hideki1,2 (AUTHOR) hideki.kitaura.b4@tohoku.ac.jp, Ohori, Fumitoshi1,3 (AUTHOR), Marahleh, Aseel2,4 (AUTHOR), Lin, Angyi1 (AUTHOR), Fan, Ziqiu1,2 (AUTHOR), Narita, Kohei1,3 (AUTHOR), Ishiyama, Tomoko1,4 (AUTHOR), Hu, Jin1 (AUTHOR), Zheng, Huidan1 (AUTHOR), Kanetaka, Hiroyasu1,3,4 (AUTHOR)
Source: International Journal of Molecular Sciences. Jun2026, Vol. 27 Issue 12, p5624. 20p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:16616596
DOI:10.3390/ijms27125624